{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:29:46Z","timestamp":1767907786714,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Burns"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.burns.2013.03.011","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T14:51:56Z","timestamp":1369061516000},"page":"1449-1455","source":"Crossref","is-referenced-by-count":51,"title":["27 years of a single burn centre experience with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality risk for causative agents"],"prefix":"10.1016","volume":"39","author":[{"given":"C.","family":"Weinand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Perbix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lefering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rathert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Spilker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2013.03.011_bib0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.burns.2013.03.011_bib0010","first-page":"39","article-title":"Burn like syndromes","volume":"12","author":"Atiyeh","year":"1999","journal-title":"Ann Burn Fire Disaster"},{"key":"10.1016\/j.burns.2013.03.011_bib0015","first-page":"422","article-title":"Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome","volume":"17","author":"Petkov","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4103\/0970-0358.90824","article-title":"Severe idiosyncratic drug reactions with epidermal necrolysis: a 5-year study","volume":"44","author":"Fadeyibi","year":"2011","journal-title":"Indian J Plast Surg"},{"key":"10.1016\/j.burns.2013.03.011_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: our current understanding","volume":"6","author":"French","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.burns.2013.03.011_bib0030","first-page":"90","article-title":"Toxic epidermal necrolysis","volume":"17","author":"Cabral","year":"2004","journal-title":"Ann Burn Fire Disasters"},{"key":"10.1016\/j.burns.2013.03.011_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis: incidence and drug aethiology in France","volume":"126","author":"Roujeau","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.burns.2009.06.213","article-title":"Toxic epidermal necrolysis (Lyell's disease)","volume":"36","author":"Lissia","year":"2010","journal-title":"Burns"},{"key":"10.1016\/j.burns.2013.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.108.5.1162","article-title":"Treatment of extensive toxic epidermal necrolysis in children","volume":"108","author":"Spies","year":"2001","journal-title":"Paediatrics"},{"key":"10.1016\/j.burns.2013.03.011_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Life-threatening acute adverse cutaneous drug reactions","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"May (5)","key":"10.1016\/j.burns.2013.03.011_bib0060","first-page":"711","article-title":"Prediction of burn mortality","volume":"154","author":"Tobiasen","year":"1982","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.burns.2013.03.011_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.burns.2013.03.011_bib0070","first-page":"142","article-title":"Sever drug induced skin reactions: clinical pattern, diagnostic and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.burns.2013.03.011_bib0075","series-title":"Braun-Falco's dermatology","first-page":"473","article-title":"Severe cutaneous adverse reactions","author":"Mockenhaupt","year":"2008"},{"key":"10.1016\/j.burns.2013.03.011_bib0080","first-page":"5","article-title":"Treatment of severe drug reactions: Stevens\u2013Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"1","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.burns.2013.03.011_bib0085","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","article-title":"Successful treatment of Stevens\u2013Johnson syndrome with steroid pulse therapy at disease onset","volume":"147","author":"Araki","year":"2009","journal-title":"Am J Opthalmol"},{"key":"10.1016\/j.burns.2013.03.011_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. A prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0095","first-page":"1477","article-title":"Toxic epidermal necrolysis: a burn-center challenge","volume":"144","author":"Peters","year":"1991","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.burns.2013.03.011_bib0100","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.burns.2013.03.011_bib0105","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809020-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.burns.2013.03.011_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2013.03.011_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bjps.2004.04.025","article-title":"Lyell syndrome revisited: analysis of 18 cases of severe bullous skin disease in a burn unit","volume":"58","author":"Neff","year":"2005","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.burns.2013.03.011_bib0120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.burns.2013.03.011_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustolosis (AGEP) \u2013 results for a multinational case\u2013control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2013.03.011_bib0135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199511303332207","article-title":"Drug therapy: management of acquired bullous skin diseases","volume":"333","author":"Fine","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.burns.2013.03.011_bib0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis (TEN) and Stevens\u2013Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis","volume":"33","author":"Stella","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.burns.2013.03.011_bib0145","first-page":"149","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"vol. 97","author":"Harr","year":"2012"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417913000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417913000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T18:57:14Z","timestamp":1539629834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417913000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0305417913000855"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2013.03.011","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}